Walleye Capital’s Clover Health Investments CLOV Stock Holding History

Walleye Capital’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$647K	Buy	123,400 +114,900	+1,352%	+$390K	﹤0.01%	2494
2026 Q1	$15K	Sell	8,500 -229,300	-96%	-$497K	﹤0.01%	4109
2025 Q4	$559K	Buy	237,800 +230,500	+3,158%	+$630K	﹤0.01%	2892
2025 Q3	$22.3K	Sell	7,300 -4,000	-35%	-$11.4K	﹤0.01%	4195
2025 Q2	$31.5K	Sell	11,300 -700	-6%	-$2.3K	﹤0.01%	4155
2025 Q1	$43.1K	Sell	12,000 -3,600	-23%	-$14.5K	﹤0.01%	3892
2024 Q4	$49.1K	Buy	+15,600	New	+$55.8K	﹤0.01%	4361

Other funds holding CLOV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Walleye Capital's CLOV Position: Q2 2026 in Review

Walleye Capital reduced its Clover Health Investments (CLOV) stake by 58% in Q2 2026, selling an estimated $48.3K and leaving 10,289 shares worth $53.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4159.

Walleye Capital first reported a position in CLOV in Q2 2020 and has held it in 11 quarters since. The position peaked at $2.26M in Q2 2020. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

Walleye Capital held 10,289 shares of Clover Health Investments worth $53.9K as of Q2 2026.
Walleye Capital sold 14,223 Clover Health Investments shares in Q2 2026, an estimated $48.3K.
Clover Health Investments made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4159 holding.
Walleye Capital first reported a position in Clover Health Investments in Q2 2020 and has held it in 11 quarters since.
Walleye Capital's Clover Health Investments position peaked at $2.26M in Q2 2020.
227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.